sk&f-38393 has been researched along with trifluoperazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, YC; Huang, WT; Lin, MT; Liu, HS; Won, SJ | 1 |
| Dawson, R; Felheim, R; Phillips, MI | 1 |
2 other study(ies) available for sk&f-38393 and trifluoperazine
| Article | Year |
|---|---|
Suppression of natural killer cell activity in mouse spleen lymphocytes by several dopamine receptor antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cytotoxicity, Immunologic; Dopamine Antagonists; Flupenthixol; Fluphenazine; Killer Cells, Natural; Mice; Mice, Inbred C3H; Pimozide; Spiperone; Spleen; Thiothixene; Trifluoperazine | 1995 |
Dopamine receptor agonists and antagonists both inhibit dopamine secretion in LLC-PK1 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Cell Line; Chlorpromazine; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Dopamine Antagonists; Epithelial Cells; Epithelium; Ergolines; Fenoldopam; Kidney; Levodopa; Phenothiazines; Quinpirole; Trifluoperazine | 1993 |